Product information and disease descriptionPlace of product in therapyApproaches to treatmentCurrent treatment options and standard of care
Supportive care and airway management
1 evidence topic · 1 source
Lonvoguran ziclumeran (lonvo-z)
Hereditary angioedema
- Manufacturer
- Intellia Therapeutics
- Regulatory submission
- Rolling BLA initiated April 2026 and accepted September 2026
- Last updated